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Endosomal pH, and Discovery of RibocilEach month, Chemistry & Biology Select highlights a selection of research reports from the recent literature.
These highlights are a snapshot of interesting research done across the field of chemical biology. Our
November 2015 selection includes an insight into non-overlapping biosynthetic pathways that lead to forma-
tion ofMycobacterium tuberculosis peptidoglycan, a newmethod to not only measure but also buffer the en-
dosomal pH using nanoparticles, and a demonstration that non-coding RNAs can be a target for antibiotic
discovery.For people living in the developed world, it
might seem that tuberculosis (TB) poses no
considerable public health risk. This,
unfortunately, is not the case, because TB
still affects a large population, particularly in
the developing world, and drug-resistant
strains continue to emerge. Although we are
now in a better situation than a century ago
and might not need poster campaigns to
remind us to fight TB with a healthy lifestyle,
TB remains relevant and the need to better
understand the basic biology of its causative
agent, Mycobacterium tuberculosis,
continues. By WPA Federal Art Project, Dis.Many Roads Lead to the TB PG
When it comes to tuberculosis (TB), the World Health Organization (WHO) is pretty
clear: this infectious disease kills more people than HIV/AIDS and is one of top 5
killers of women between the age of 20 and 59. WHO also highlights that the num-
ber of reported cases of multi-drug-resistant TB (MDR-TB) and extensively drug-
resistant TB (XDR-TB) is growing at an alarming rate. - TB, however, is not a new
disease: it’s been the foe of humanity for millennia, and so prominent in the public
life around the turn of 20th century that it inspired numerous works of art while at
the same time wiping out many of prominent artists, writers, philosophers, public
figures, and millions of others.
Today, TB diagnosis is no longer a certain death sentence, but the disease is still
very serious, especially in immunocompromised individuals, and the emergence of
MDR-TB and XDR-TB make further research into the biology of TB and its causa-
tive agent, Mycobacterium tuberculosis (Mtb), exceptionally important. There are
many aspects of Mycobacteria, Mtb included, that make them unique in the bac-
terial world; for example,Mtb, like many other bacteria, has a peptidoglycan (PG)
cell wall, but there are so many differences in how Escherichia coli, one of the fa-
vorite model organisms in microbiology, makes its PG and Mtb that mechanistic
and structural insights obtained using E. coli often don’t apply toMtb. To address
this, Kieser et al. take a closer look at what exactly happens inMtb by focusing on
three enzymes known to be important for PG biosynthesis: PonA1 and PonA2,
responsible for glycan polymerization and peptide cross-linking, and LdtB, amajor
L,D-transpeptidase in Mtb that cross-links the PG peptides. The authors employ
transposon mutagenesis combined with high-throughput sequencing to map out
all the genes in the Mtb genome linked to genes coding for PonA1, PonA2, and
LdtB, and see that the three genes have different connections and roles in distinct
genetic networks. The most interesting observation Kieser et al. made is that each
network displays different antibiotic tolerance, which suggests that dissecting the
exact roles each enzyme plays in PG biosynthesis andMtb physiology might lead
to opportunities to fine-tune antibiotic cocktails and optimize treatment strategies
to deliver a more effective punch toMtb. The work also highlights that despite sim-
ilarity between biosynthetic enzymes, as in the case of PonA1 and PonA2, we
should not assume functional redundancy.
Kiester et al. (2015). Proc. Natl. Acad. Sci. USA. 112, 13087–13092. http://dx.doi.
org/10.1073/pnas.15141351124 [Public domain], via Wikimedia Commons.Measuring and Buffering Endosomal pH
Ask any biology student what the physiological pH is and you are likely to have 7.4 offered as an answer. This pH value is
actually the pH of blood and commonly referred to as the physiological pH. The actual pH values, however, vary from tis-
sue to tissue, from cell type to cell type, and within a cell, from one cellular compartment to the next; for example, endo-
somes, organelles involved in transporting cargo from the outside of the cell to the lysosome or other locations, in the
process known as endocytosis, go through several stages, each marked by a specific shift in the endosomal pH value.
These changes in pH are programmed and structured in a way that ensures efficient delivery of the cargo to its final
destination.Chemistry & Biology 22, November 19, 2015 ª2015 Elsevier Ltd All rights reserved 1415
Universal pH indicator paper is one of the
basic tools in any chemical and biological
lab. Wang et al. now develop a set of
nanoparticle-based pH indicators and
buffers that enter the cell via endocytosis
and stay in the endosome, thus allowing one
to monitor pH transitions that take place
during endocytosis and to relate them to
cellular physiology and metabolism. Image




1416 Chemistry & Biology 22, November 19, 2In general, pH is not hard to measure, and in some cases, you can get a good
accuracy read by using nothing fancier than a bit of pH indicator paper that
changes color depending on the pH value of the solution to which it has been
exposed. However, measuring pH inside an endosome is not as straightforward.
Although the method is conceptually similar to using pH indicator paper because
it depends on detecting a change in color, it is often difficult to implement in a tar-
getedway as the dyes used are often deposited not only in endosomes but in other
cellular compartments. Recently, Wang et al. developed amethod that overcomes
these obstacles by using ultra-pH-sensitive (UPS) nanoparticles. These particles
are made of poly(ethylene oxide) (PEO) and an ionizable random copolymer block
that defines their physicochemical properties, such as the pKa value. The copol-
ymers assemble into micelles at higher pH values and dissociate once the pH in
the micelles falls below a threshold pH; this makes the copolymers very sensitive
to pH changes and potentially useful as pH indicators. More importantly for
the purpose of measuring endosomal pH, UPS nanoparticles are taken up by
and stay in endosomes throughout their intracellular journey. What Wang et al.
demonstrate is that UPS nanoparticles have a large buffer capacity and can act
as ‘‘proton sponges’’ to soak up excess protons in specific pH ranges that are
functionally relevant: 6.0-6.5 in early endosomes, 5.0-5.5 in late endosomes,
and 4.0-4.5 in lysosomes. Wang et al. provide several examples of how UPS
nanoparticles can be used to get deeper insight into physiology and metabolism
and how they are affected by pH transitions.
Wang et al. (2015). Nat. Commun. PublishedOctober 5, 2015. http://dx.doi.org/10.
1038/ncomms9524A Light at the End of a Tunnel
Everything is not well in the world of antibiotic drug discovery and development. Many would actually say that ‘‘not well’’ is
putting mildly, because the discovery of new antibiotics has been deprioritized by many pharmaceutical companies. At the
same time as R&D efforts have been slowing down, the rate at which bacteria develop resistance to existing agents has
been increasing, leading to big headlines with a word ‘‘superbug’’ in them.
In order to tackle the crisis, we not only need to continue to invest in antibiotic research but also to continue to question our
assumptions about what constitutes a viable antibacterial target and a likely antibacterial agent. Recent work by Howe et al.
takes antibiotic discovery into a new direction. The authors, who are all members of Merck Research Laboratories, a good
sign that antibiotic drug discovery can still thrive in big pharma, focus on investigating what it would take to be able to target
bacterial riboflavin riboswitches. Riboswitches are regions within messenger RNAs that do notcarry any coding information,
but they do play an important role in the regulation of gene expression. They bind to small molecules, most commonly different
metabolites, which leads to specific conformational changes within the RNA and modulates the expression of a given gene.
In the case of riboflavin riboswitches, these bind flavin mononucleotide (FMN) and can be inhibited by related riboflavin
derivatives. However, due to significant side effects from the lack of selectivity, riboflavin derivatives are not viable antibiotic
candidates. Howe et al. screen a collection of approximately 57,000 compounds with known antibacterial activity and identify
a compound they name ribocil, which binds the FMN riboswitch. The structural analysis shows that ribocil assumes a similar
binding pose in the FMN riboswitch as a natural ligand. Ribocil is specific for FMN riboswitches and has antibacterial effects
that can be reversed by the addition of exogenous riboflavin. The work opens future opportunities in the exploration of ribos-
witch targeting as a broader antibiotic strategy and it is remarkable as an example of how shifting the focus from target based
to phenotypic screening, or from protein-centric view of targets to an RNA-centric perspective, is needed to shift the discus-
sion in antibiotic discovery and development from lamenting past glory to rejoicing in the future.
Howe et al. (2015). Nature. 526, 672–677. http://dx.doi.org/10.1038/nature15542
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